Results 161 to 170 of about 50,167 (231)

Large‐scale meta‐analysis of infection risk with JAK–STAT inhibitors in 29,000 patients

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 10, Page 1662-1674, October 2026.
In this large meta‐analysis of 74 randomized controlled trials involving more than 29,000 patients, JAK–STAT inhibitors were associated with an increased risk of influenza, bronchitis and herpes infections, particularly herpes zoster, while an increased risk of serious opportunistic or fungal infections was not observed.
Máté Krebs   +10 more
wiley   +1 more source

Tofacitinib as a Promising Therapeutic Option for Vitiligo: A Systematic Review. [PDF]

open access: yesClin Cosmet Investig Dermatol
Ahmadkhani M   +3 more
europepmc   +1 more source

JAK Inhibitors for Alopecia Areata: Approved Therapies, Efficacy, and Unanswered Questions. [PDF]

open access: yesDrug Des Devel Ther
Wu ZX   +10 more
europepmc   +1 more source

Differential regulation of SOCS signalling and immunoproteasome pathways by JAK inhibitors and TNF inhibitors in rheumatoid arthritis. [PDF]

open access: yesArthritis Res Ther
Ghannam K   +10 more
europepmc   +1 more source

Effectiveness and Safety Profile of Oral Tofacitinib in Alopecia Areata: An Observational Study from a Tertiary Hospital. [PDF]

open access: yesIndian J Dermatol
Bhat YJ   +10 more
europepmc   +1 more source

Beyond class switching in multi-refractory inflammatory bowel disease: Nine case reports and review of literature. [PDF]

open access: yesWorld J Gastrointest Pharmacol Ther
Soldera J   +4 more
europepmc   +1 more source

Effect of JAK Inhibitors on Fatigue and Sleep Quality in Patients with Rheumatoid Arthritis: A Narrative Review. [PDF]

open access: yesJ Clin Med
Kowalska A   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy